Defective adenoviruses as novel vaccines for the Flaviviridae.
about
Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2Recent advancement in flavivirus vaccine development.Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors.A molecular evaluation of dengue virus pathogenesis and its latest vaccine strategies.CD8+ T-Cell Tolerance can be Broken by an Adenoviral Vaccine While CD4+ T-Cell Tolerance is Broken by Additional Co-administration of a Toll-Like Receptor Ligand
P2860
Defective adenoviruses as novel vaccines for the Flaviviridae.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Defective adenoviruses as novel vaccines for the Flaviviridae.
@en
Defective adenoviruses as novel vaccines for the Flaviviridae.
@nl
type
label
Defective adenoviruses as novel vaccines for the Flaviviridae.
@en
Defective adenoviruses as novel vaccines for the Flaviviridae.
@nl
prefLabel
Defective adenoviruses as novel vaccines for the Flaviviridae.
@en
Defective adenoviruses as novel vaccines for the Flaviviridae.
@nl
P1476
Defective adenoviruses as novel vaccines for the Flaviviridae.
@en
P2093
Stephenson J
P304
P356
10.1016/S0928-0197(98)00038-5
P577
1998-07-01T00:00:00Z